Evidence map›Paper›PMID 28700752›Full record

ArticlePloS one2017

Role of a novel immune modulating DDR2-expressing population in silica-induced pulmonary fibrosis.

Lindsay T McDonald, Sara D Johnson, Dayvia L Russell, M Rita I Young, Amanda C LaRue

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. 'Youthful' phenotype of c-KitCellular and molecular life sciences : CMLS · 2022
    Article
  4. Single-cell RNA sequencing reveals the induction of novel myeloid and myeloid-associated cell populations in visceral fat with long-term obesity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  5. Healing after COVID-19: are survivors at risk for pulmonary fibrosis?American journal of physiology. Lung cellular and molecular physiology · 2021
    Review
  6. Pressure overload generates a cardiac-specific profile of inflammatory mediators.American journal of physiology. Heart and circulatory physiology · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lindsay T McDonaldResearch Services, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States of America.ORCID http://orcid.org/0000-0003-3967-4435
Sara D JohnsonResearch Services, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States of America.
Dayvia L RussellResearch Services, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States of America.
M Rita I YoungResearch Services, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States of America.
Amanda C LaRueResearch Services, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States of America.
Medical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
BLRD VA I01 BX002277NCI NIH HHS P30 CA138313
6 · The paper itself

Abstract

Micro-injuries associated with chronic inhaled particle exposures are linked with activation of the immune response and are thought to contribute to progression of fibrotic disease. In the pulmonary environment, we have previously demonstrated a heterogeneous population of circulating fibroblast precursors (CFPs), which are defined by expression of the pan-leukocyte marker CD45 and the collagen receptor, discoidin domain receptor-2 (DDR2). This population is derived from the hematopoietic stem cell, expresses collagen, and has a fibroblastic morphology in vitro. Herein, we demonstrate a novel subset of CFPs expressing immune markers CD11b, CD11c, and major histocompatibility complex II (MHC II). The CFP population was skewed toward this immune marker expressing subset in animals with silica-induced pulmonary fibrosis. Data indicate that this CFP subset upregulates co-stimulatory molecules and MHC II expression in response to silica-induced fibrosis in vivo. Functionally, this population was shown to promote T cell skewing away from a Th1 response and toward a pro-inflammatory profile. These studies represent the first direct flow cytometric and functional evaluation of the novel immune marker expressing CFP subset in an exposure-induced model of pulmonary fibrosis. Elucidating the role of this CFP subset may enhance our understanding of the complex immune balance critical to mediating exposures at the pulmonary-host interface and may be a valuable target for the treatment of exposure-induced pulmonary fibrosis.

Indexed as

AnimalsAntigens, CDCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDiscoidin Domain Receptor 2Disease Models, AnimalFibroblastsHistocompatibility Antigens Class IILungMaleMice, Inbred C57BLPhenotypePulmonary FibrosisSilicon DioxideAntigens, CDDiscoidin Domain Receptor 2Histocompatibility Antigens Class IISilicon Dioxide

Identifiers

PMID28700752
PMCPMC5507261
OpenAlexW2734421385

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.